1. Home
  2. LGO vs TVGN Comparison

LGO vs TVGN Comparison

Compare LGO & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LGO

Largo Inc.

HOLD

Current Price

$0.95

Market Cap

95.8M

Sector

N/A

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

HOLD

Current Price

$0.39

Market Cap

89.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGO
TVGN
Founded
1988
2020
Country
Canada
United States
Employees
N/A
N/A
Industry
Blank Checks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
95.8M
89.6M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
LGO
TVGN
Price
$0.95
$0.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$3.30
$5.00
AVG Volume (30 Days)
377.3K
1.4M
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$111,884,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$53.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$0.36
52 Week High
$2.70
$1.92

Technical Indicators

Market Signals
Indicator
LGO
TVGN
Relative Strength Index (RSI) 42.13 40.57
Support Level $0.88 $0.36
Resistance Level $1.11 $0.47
Average True Range (ATR) 0.07 0.03
MACD 0.00 0.00
Stochastic Oscillator 26.98 26.82

Price Performance

Historical Comparison
LGO
TVGN

About LGO Largo Inc.

Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Share on Social Networks: